review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0025-7753(04)74300-6 |
P698 | PubMed publication ID | 15117649 |
P50 | author | Amelia Marti | Q47223163 |
P2093 | author name string | J Alfredo Martínez | |
María del Carmen Ochoa | |||
P2860 | cites work | Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function | Q24561366 |
Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes | Q24564520 | ||
The G-308A variant of the Tumor Necrosis Factor-alpha (TNF-alpha) gene is not associated with obesity, insulin resistance and body fat distribution | Q24804687 | ||
A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans | Q28191413 | ||
Uncoupling protein 3 gene is associated with body composition changes with training in HERITAGE study | Q28201029 | ||
A prevalent polymorphism in the promoter of the UCP3 gene and its relationship to body mass index and long term body weight change in the Danish population | Q28203578 | ||
Organisation of the coding exons and mutational screening of the uncoupling protein 3 gene in subjects with juvenile-onset obesity | Q28264342 | ||
Obesity associated with a mutation in a genetic regulator of adipocyte differentiation | Q28283800 | ||
Association between uncoupling protein 3 gene and obesity-related phenotypes in the Québec Family Study | Q28362781 | ||
Uncoupling protein 3 and peroxisome proliferator-activated receptor gamma2 contribute to obesity and diabetes in palauans | Q32125846 | ||
The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes | Q33899154 | ||
A polymorphism in the 5' untranslated region and a Met229-->Leu variant in exon 5 of the human UCP1 gene are associated with susceptibility to type II diabetes mellitus | Q33943770 | ||
The sympathetic nervous system and obesity: role in aetiology and treatment | Q34741897 | ||
The human obesity gene map: the 2002 update | Q35084465 | ||
The human obesity gene map: the 2003 update | Q35715184 | ||
Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African American, white, and Asian children | Q35830761 | ||
An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes. | Q39511136 | ||
Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene are not associated with obesity in Japanese men | Q73034893 | ||
Impact of the v/v 55 polymorphism of the uncoupling protein 2 gene on 24-h energy expenditure and substrate oxidation | Q73170888 | ||
Frequency of and interaction between polymorphisms in the beta3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans | Q73228428 | ||
Association of sets of alleles of genes encoding beta3-adrenoreceptor, uncoupling protein 1 and lipoprotein lipase with increased risk of metabolic complications in obesity | Q73510775 | ||
The beta 3-adrenergic receptor gene and obesity in a population sample of African Americans | Q73599728 | ||
A genetic variation in the 5' flanking region of the UCP3 gene is associated with body mass index in humans in interaction with physical activity | Q73640736 | ||
The association between the val/ala-55 polymorphism of the uncoupling protein 2 gene and exercise efficiency | Q73799823 | ||
Tumor necrosis factor-alpha--308 G/A polymorphism in obese Caucasians | Q73799897 | ||
Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity | Q73884891 | ||
Uncoupling protein 2 region on chromosome 11q13 is not linked to markers of obesity in familial type 2 diabetes | Q73929169 | ||
Linkage exclusion analysis of the chromosome 11 region containing UCP2 and UCP3 with obesity-related phenotypes in Mexican Americans | Q74200439 | ||
[Genetic studies of obesity in humans] | Q74243280 | ||
Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity | Q74313824 | ||
Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus | Q74459280 | ||
Molecular screening of uncoupling protein 2 gene in patients with noninsulin-dependent diabetes mellitus or obesity | Q77114119 | ||
The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females | Q77331640 | ||
Screening for variants of the uncoupling protein 2 gene in Japanese patients with non-insulin-dependent diabetes mellitus | Q77779460 | ||
The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects | Q77924533 | ||
Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects | Q78003957 | ||
The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. | Q51549887 | ||
Circulating ghrelin levels are decreased in human obesity. | Q51549919 | ||
Evidence for gene-nutrient interaction at the PPARgamma locus. | Q51550350 | ||
Association of -3826 G variant in uncoupling protein-1 with increased BMI in overweight Australian women. | Q51551577 | ||
Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men. | Q51551763 | ||
Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. | Q51553957 | ||
Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the beta3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia. | Q51566671 | ||
The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. | Q51568495 | ||
Mutational analysis of the coding region of the uncoupling protein 2 gene in obese NIDDM patients: impact of a common amino acid polymorphism on juvenile and maturity onset forms of obesity and insulin resistance. | Q51571842 | ||
Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratio. | Q51672678 | ||
Phenotypic characterization of the beta3-adrenergic receptor mutation and the uncoupling protein 1 polymorphism in Japanese men. | Q54095328 | ||
Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. | Q54102579 | ||
Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. | Q54164957 | ||
Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism. | Q54762887 | ||
Effect of Trp64Arg mutation of the β3‐adrenergic receptor gene and C161T substitution of the peroxisome proliferator activated receptor γ gene on obesity in Japanese children | Q54777045 | ||
Pilot study examining the frequency of several gene polymorphisms in a morbidly obese population. | Q54791585 | ||
Skeletal muscle UCP2 and UCP3 expression in trained and untrained male subjects | Q55162997 | ||
Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations | Q57242012 | ||
Interactions among the α2-, β2-, and β3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study | Q57316425 | ||
DNA polymorphism in the uncoupling protein 1 (UCP1) gene has no effect on obesity related phenotypes in the Swedish Obese Subjects cohorts | Q57316435 | ||
Linkage Between Markers in the Vicinity of the Uncoupling Protein 2 Gene and Resting Metabolic Rate in Humans | Q57316444 | ||
Genetic factors as predictors of weight gain in young adult Dutch men and women | Q57418378 | ||
Uncoupling protein 3 genetic variants in human obesity: the c-55t promoter polymorphism is negatively correlated with body mass index in a UK Caucasian population | Q57840328 | ||
Genetic Variation and Obesity in Australian Women: A Prospective Study | Q58647789 | ||
UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and b3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations | Q58679006 | ||
TRP64ARG polymorphism of the beta3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle | Q59284112 | ||
Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women | Q60472326 | ||
Synergistic effect of polymorphisms in uncoupling protein 1 and β3-adrenergic receptor genes on long-term body weight change in Finnish type 2 diabetic and non-diabetic control subjects | Q61713509 | ||
Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2 | Q61928062 | ||
The hormone-sensitive lipase i6 gene polymorphism and body fat accumulation | Q63502701 | ||
Two Polymorphisms in the Peroxisome Proliferator-Activated Receptor- Gene Are Associated with Severe Overweight among Obese Women | Q64355583 | ||
The Trp64Arg Polymorphism of the 3-Adrenergic Receptor Gene: Lack of association with NIDDM and features of insulin resistance syndrome | Q64355585 | ||
Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects | Q72956092 | ||
Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin. | Q39556349 | ||
Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a sub-sample of the EPIC-Heidelberg cohort | Q40625761 | ||
No relationship between identified variants in the uncoupling protein 2 gene and energy expenditure | Q42460607 | ||
A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians | Q42800233 | ||
Frequency and significance of the A-->G (-3826) polymorphism in the promoter of the gene for uncoupling protein-1 with regard to metabolic parameters and adipocyte transcription factor binding in a large population-based Caucasian cohort | Q42811435 | ||
A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity | Q43542493 | ||
G-308A polymorphism of the tumor necrosis factor alpha gene promoter and salivary cortisol secretion | Q43601844 | ||
Frequency and significance of Pro12Ala and Pro115Gln polymorphism in gene for peroxisome proliferation-activated receptor-gamma regarding metabolic parameters in a Caucasian cohort | Q43667388 | ||
Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects | Q43709078 | ||
The Arg16Gly polymorphism of human beta2-adrenoreceptor is associated with type 2 diabetes in Taiwanese people | Q43742365 | ||
A common hormone-sensitive lipase i6 gene polymorphism is associated with decreased human adipocyte lipolytic function | Q43748969 | ||
Genetic variation at the uncoupling protein 1, 2 and 3 loci and the response to long-term overfeeding. | Q43771731 | ||
Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance. | Q43803927 | ||
The effect of the Gly16Arg polymorphism of the beta(2)-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity | Q43819862 | ||
The TNF alpha/G-308A polymorphism influences insulin sensitivity in offspring of patients with coronary heart disease: the European Atherosclerosis Research Study II. | Q43912967 | ||
Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients | Q43943750 | ||
Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity | Q43990202 | ||
Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects | Q44037426 | ||
Beta(2)-adrenergic receptor mutation and abdominal obesity risk: effect modification by gender and HDL-cholesterol | Q44058782 | ||
The risk of obesity and the Trp64Arg polymorphism of the beta(3)-adrenergic receptor: effect modification by age. | Q44095985 | ||
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus | Q44129704 | ||
Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals. | Q44158440 | ||
Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population | Q44172019 | ||
Lack of association between the uncoupling protein-2 Ala55Val gene polymorphism and phenotypic features of the Metabolic Syndrome | Q44183775 | ||
The influence of the Pro12Ala mutation of the PPAR-gamma receptor gene on metabolic and clinical characteristics in treatment-naïve patients with type 2 diabetes | Q44198031 | ||
A maximal effort trial in obese women carrying the beta2-adrenoceptor Gln27Glu polymorphism. | Q44218784 | ||
The polymorphism of the beta3-adrenergic receptor gene is associated with reduced low-density lipoprotein particle size | Q44368980 | ||
Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects | Q44392900 | ||
A 45‐bp Insertion/Deletion Polymorphism of Uncoupling Protein 2 in Relation to Obesity in Tongans | Q44400038 | ||
CHO intake alters obesity risk associated with Pro12Ala polymorphism of PPARgamma gene | Q44439174 | ||
Analysis of the Relationship between PPAR-γ 2 Gene Variants and Severe Insulin Resistance in Obese Patients with Impaired Glucose Tolerance | Q44440946 | ||
The TNF-alpha gene NcoI polymorphism at position -308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity. | Q44441370 | ||
The effect of the -308A allele of the TNF-alpha gene on insulin action is dependent on obesity | Q44509851 | ||
Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men. | Q44997850 | ||
Effects of beta2-adrenergic receptor gene variants on adiposity: the HERITAGE Family Study | Q46347272 | ||
Racial differences in the relation between uncoupling protein genes and resting energy expenditure | Q46485912 | ||
No effect of the Trp64Arg beta(3)-adrenoceptor gene variant on weight loss, body composition, or energy expenditure in obese, caucasian postmenopausal women | Q47184694 | ||
An untranslated insertion variant in the uncoupling protein 2 gene is not related to body mass index and changes in body weight during a 26-year follow-up in Danish Caucasian men. | Q47248348 | ||
Additive effects of the mutations in the beta3-adrenergic receptor and uncoupling protein-1 genes on weight loss and weight maintenance in Finnish women | Q47274507 | ||
Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians. | Q47700926 | ||
Human hormone-sensitive lipase: genetic mapping, identification of a new dinucleotide repeat, and association with obesity and NIDDM. | Q48039334 | ||
Studies of the synergistic effect of the Trp/Arg64 polymorphism of the beta3-adrenergic receptor gene and the -3826 A-->G variant of the uncoupling protein-1 gene on features of obesity and insulin resistance in a population-based sample of 379 youn | Q50567719 | ||
Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on basal metabolic rate in obese Finns. | Q50896734 | ||
Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study. | Q51536333 | ||
Role of ghrelin polymorphisms in obesity based on three different studies. | Q51541254 | ||
Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity. | Q51549578 | ||
P433 | issue | 14 | |
P407 | language of work or name | Spanish | Q1321 |
P921 | main subject | obesity | Q12174 |
P304 | page(s) | 542-551 | |
P577 | publication date | 2004-04-01 | |
P1433 | published in | Medicina clínica | Q26854009 |
P1476 | title | [Obesity studies in candidate genes]. | |
P478 | volume | 122 |
Q57599356 | ADRB3andPPARγ2gene polymorphisms and their association with cardiovascular disease risk in postmenopausal women |
Q46222038 | G allele of the -930A>G polymorphism of the CYBA gene is associated with insulin resistance in obese subjects |
Q58075052 | Gene–gene interaction between PPARγ2 and ADRβ3 increases obesity risk in children and adolescents |
Q28581080 | High-fat feeding period affects gene expression in rat white adipose tissue |
Q55032731 | Individual Responsiveness to Exercise-Induced Fat Loss and Improvement of Metabolic Profile in Young Women is Associated with Polymorphisms of Adrenergic Receptor Genes. |
Q59283484 | Interaction between genes and lifestyle factors on obesity |
Q54302905 | Leptin receptor gene K656N polymorphism is associated with low body fat levels and elevated high-density cholesterol levels in Mexican children and adolescents. |